Momenta Pays Out On Enoxaparin Shut-Out

Settles Class-Action Purchasers’ Suit

 
• By Aidan Fry
  
Money_Notes
Momenta has agreed to pay $35.0m to settle a class-action suit brought by US purchasers of enoxaparin • Source: Shutterstock

More from Legal & IP

More from Generics Bulletin